Incannex Healthcare (ASX:IHL) Share Price and News - StockTrack

Market Cap (29-Nov) $65,067,412 (361st)	Close (30-Jun) $0.100 0 (0%)	Volume (30-Jun) 1,754,344	Shortsold (29-Nov) 5,010,077 (0.32%) (345th)
52w High $0.000	52w Low $0.000	P/E -	EPS -1.3

	Subject
	IHL IHL Ann: Application for quotation of securities - IHL
	1 (current) 2 3
	IHL IHL Ann: Annual Report to Shareholders
	IHL IHL Ann: Appendix 4E & Financial Report for the year ended 30 June 21
	IHL IHL Ann: Application for quotation of securities - IHL
	IHL IHL Ann: Cleansing Notice - Options Exercise
	IHL IHL Ann: Notification regarding unquoted securities - IHL
	IHL IHL Ann: Notice of General Meeting/Proxy Form
	IHL IHL Ann: IHL files Form F-1 registration statement with SEC
	IHL IHL Ann: Cleansing Notice - Options Exercise
	IHL IHL Ann: Application for quotation of securities - IHL
	IHL IHL Ann: Incannex Psychedelic Therapies Presentation
	IHL IHL Ann: HREC and FDA pre-IND request for Psilocybin Therapy
	IHL IHL Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IHL IHL Ann: IHL commences IHL-675A trial and patent application
	IHL IHL Ann: IHL-42X patent update & open label extension study approval
	IHL IHL Ann: Cleansing Notice and Appendix 2A - Options Exercise
	IHL IHL Ann: Trading Halt
	IHL IHL Ann: Incannex engages Procaps for production of IHL-675A
	IHL IHL Ann: Company Secretary Appointment/Resignation
	IHL IHL Ann: Diectors' Disclosures (4 x Appendix 3Y)
	IHL IHL Ann: Changes to Securities on Issue
	IHL IHL Ann: IHL-216A formulation and manufacturing appointment
	IHL IHL Ann: Escrow release
	IHL IHL Ann: Cleansing Notice and Appendix 2A
	IHL IHL Ann: Cleansing Notice and Apendix 2A - Options Exercise
	IHL IHL Ann: IHL-42X OSA Update
	IHL IHL Ann: Cleansing Notice and Appendix 2A - Options exercise
	IHL IHL Ann: Appendix 3Y - Peter Widdows
	IHL IHL Ann: Cleansing Notice and Appendix 2A - Options exercise
	IHL IHL Ann: Quarterly Activities Report - Mar21
	IHL IHL Ann: Positive FDA Pre-IND meeting guides IHL-675A development
	IHL IHL Ann: Cleansing Notice and Appendix 2A
	IHL IHL Ann: IHL-675A Pre-IND meeting with FDA update
	IHL IHL Ann: IHL-675A outperforms existing treatment for arthritis
	IHL IHL Ann: Trading Halt
	IHL IHL Ann: IHL-216A to be assessed in NFL model of concussion
	IHL IHL Ann: Cleansing Notice and Appendix 2A
	IHL IHL Ann: Change in Director's Interest
	IHL IHL Ann: Appendix 4D correction
	IHL IHL Ann: Cleansing Notice and Appendix 2A
	IHL IHL Ann: Appendix 3G
	IHL IHL Ann: Half Yearly Report and Accounts
	IHL IHL Ann: Proposed issue of Securities - IHL
	IHL IHL Ann: IHL-675A in vivo results for Inflammatory Bowel Disease
	IHL IHL Ann: Trading Halt
	IHL IHL Ann: IHL appoints EAS Advisors LLC to facilitate US listing
	IHL IHL Ann: IHL-675A in vivo results for COPD and asthma
	IHL IHL Ann: Quarterly Activities Report - Dec 2020
	IHL IHL Ann: Cleansing Notice and Appendix 2A
	IHL IHL Ann: Incannex AGM Presentation

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
29-Nov	$0.04	0	0.00 (0.00%)
28-Nov	$0.04	0	0.00 (0.00%)
27-Nov	$0.04	0	0.00 (0.00%)
24-Nov	$0.04	0	0.00 (0.00%)
23-Nov	$0.04	0	0.00 (0.00%)
22-Nov	$0.04	0	0.00 (0.00%)
21-Nov	$0.04	0	0.00 (0.00%)
20-Nov	$0.04	0	0.00 (0.00%)
17-Nov	$0.04	61,360,016	0.00 (10.87%)
16-Nov	$0.05	21,319,430	-0.01 (20.69%)
15-Nov	$0.06	19,039,135	+0.00 (7.41%)
14-Nov	$0.05	15,753,516	-0.01 (10.00%)
13-Nov	$0.06	3,156,107	0.00 (3.23%)
10-Nov	$0.06	4,711,739	0.00 (4.62%)
09-Nov	$0.07	3,505,926	-0.01 (7.14%)
1 up, 6 down, and 8 flat days

High $0.11	Low $0.10	Trades 225	Turnover $176,834	Volume 1,754,344
30 June 2023 at 4:10pm

High $0.11	Low $0.10	Trades 225	Turnover $176,834	Volume 1,754,344
30 June 2023 at 4:10pm

Incannex Healthcare Health Care

$0.100 -0.005 (-4.76%)

$0.100 -0.005 (-4.76%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices